What Has Been The Evolution of the Muscle Spasticity Market in Recent Years?
The muscle spasticity market has seen considerable growth due to a variety of factors.
• The muscle spasticity market has seen strong growth. It will increase from $4.19 billion in 2024 to $4.57 billion in 2025 at a CAGR of 9.1%.
The historical growth is attributed to more research investments, expanded clinical indications, favorable regulatory approvals, and the rising prevalence of multiple sclerosis.
What Is the Forecasted Market Size and Growth Rate for The Muscle Spasticity Market Size In The Coming Years?
The muscle spasticity market is expected to maintain its strong growth trajectory in upcoming years.
• The muscle spasticity market is expected to grow to $6.41 billion by 2029, with a CAGR of 8.8%.
The growth is attributed to patient-centric care, expanding distribution channels, quality of life improvement, drug delivery system development, and biomarker discoveries. Key trends include value-based reimbursement models, AI and machine learning integration, telehealth adoption, neurostimulation techniques, and regenerative medicine.
What Factors Are Driving Growth In The Muscle Spasticity Market?
The rising prevalence of musculoskeletal disorders is also expected to drive the muscle spasticity market. Musculoskeletal disorders, which affect movement and cause pain, are increasing due to aging populations and lifestyle factors. Treatments for muscle spasticity aim to alleviate symptoms and improve mobility. In 2022, Amgen reported a 68% projected increase in osteoporosis-related fractures by 2040.
What Are The Main Segments Of The Global Muscle Spasticity Market?
The muscle spasticity market covered in this report is segmented –
1) By Drug Type: Baclofen, Botulinum Toxin, Diazepam, Dantrolene Sodium, Other Drugs
2) By Route Of Administration: Oral, Intramuscular, Other Routes
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Baclofen: Oral Baclofen, Intrathecal Baclofen (Pump)
2) By Botulinum Toxin: Botox (Botulinum Toxin Type A), Dysport (Botulinum Toxin Type A), Xeomin (Botulinum Toxin Type A), Myobloc (Botulinum Toxin Type B)
3) By Diazepam: Oral Diazepam, Injectable Diazepam
4) By Dantrolene Sodium: Oral Dantrolene, Injectable Dantrolene
5) By Other Drugs: Tizanidine, Clonidine, Gabapentin, Other Muscle Relaxants, Selective Serotonin Reuptake Inhibitors (SSRIs)
Pre-Book The Muscle Spasticity Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Emerging Trends Are Influencing The Growth Of The Muscle Spasticity Market?
Key players in the muscle spasticity market are prioritizing the creation of oral suspensions to address muscle spasms linked to ailments like multiple sclerosis and spinal cord injuries. These oral suspensions are liquid drugs with evenly distributed active compounds that are consumed orally. For example, in April 2024, ANI Pharmaceuticals, a pharmaceutical manufacturing firm based in the US, introduced baclofen oral suspension. This medicine, a generic form of fleqsuvy, helps in alleviating muscle spasms associated with conditions such as multiple sclerosis and spinal cord injuries by aiding in muscle relaxation.
Who Are the Key Players In The Muscle Spasticity Market?
Major companies operating in the muscle spasticity market are:
• F. Hoffmann-La Roche AG
• AbbVie Inc.
• Abbott Laboratories
• Novartis AG
• Medtronic plc
• Teva Pharmaceutical Industries Ltd.
• Boston Scientific Corporation
• Sun Pharmaceutical Industries Ltd.
• Ipsen Pharma
• Hikma Pharmaceuticals plc
• Endo Pharmaceuticals Inc.
• Lupin Pharmaceuticals Inc.
• Amneal Pharmaceuticals Inc.
• Mallinckrodt Pharmaceuticals
• Neurocrine Biosciences Inc.
• Merz Pharmaceuticals GmbH
• Beximco Pharmaceuticals Ltd.
• ANI Pharmaceuticals Inc.
• Taj Pharmaceuticals Limited
• Revance Therapeutics Inc.
• Acorda Therapeutics Inc.
• Mylan N.V.
• Camber Pharmaceuticals Inc.
• Saol Therapeutics Inc.
• Zydus Cadila
What Is The Most Dominant Region In The Muscle Spasticity Market?
North America was the largest region in the muscle spasticity market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the muscle spasticity market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
